Samuel Abshire, MD
Geriatric Medicine · Haynesville, LANPI 1407883820
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $745 and has fallen 55.1% since, to $335 in 2025. Among geriatric medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$329
- Bayer$272
- AstraZeneca$235
- Harmony Biosciences LLC$219
- Astellas Pharma US Inc$211
- Paratek Pharmaceuticals, Inc.$165
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,54093%
- Education$2007%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $329 |
| Bayer | 14 | $272 |
| AstraZeneca | 7 | $235 |
| Harmony Biosciences LLC | 7 | $219 |
| Astellas Pharma US Inc | 7 | $211 |
| Paratek Pharmaceuticals, Inc. | 4 | $165 |
| Boston Scientific | 2 | $133 |
| Merck | 8 | $116 |
| Kowa Pharmaceuticals America, Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Pfizer | 7 | $91 |
| Johnson & Johnson | 6 | $88 |
| Mylan Specialty L.p. | 3 | $73 |
| Novo Nordisk | 4 | $65 |
| Indivior Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| Boehringer Ingelheim | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Eisai Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| GSK | 1 | $29 |
| Avanir Pharmaceuticals, Inc. | 2 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| AbbVie | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Athena Bioscience, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
- NUZYRA$125
- GENERAL PAIN MANAGEMENT$115
How this compares
$2,740 in reported general payments places this provider in the 95th percentile of 40 geriatric medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 239 | $151,713 |
| JanuviaSitagliptin Phosphate | 99 | $86,882 |
| MyrbetriqMirabegron | 137 | $78,873 |
| JardianceEmpagliflozin | 80 | $59,433 |
| OzempicSemaglutide | 50 | $46,324 |
| FarxigaDapagliflozin Propanediol | 44 | $33,944 |
| TrulicityDulaglutide | 22 | $26,425 |
| EntrestoSacubitril/Valsartan | 48 | $24,411 |
| XareltoRivaroxaban | 25 | $23,359 |
| JanumetSitagliptin Phos/Metformin Hcl | 25 | $23,275 |
| GemtesaVibegron | 37 | $19,715 |
| TradjentaLinagliptin | 25 | $18,419 |
| Cinacalcet Hcl | 12 | $15,299 |
| MounjaroTirzepatide | 14 | $14,811 |
| LinzessLinaclotide | 30 | $12,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $91 | $151,713239 claims |
| MerckJanuvia, Janumet | $116 | $110,157124 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Jentadueto Xr | $47 | $93,506136 claims |
| Astellas Pharma US IncMyrbetriq | $211 | $78,873137 claims |
| Novo NordiskOzempic, Rybelsus | $65 | $57,89962 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $32 | $41,23636 claims |
| AstraZenecaFarxiga | $235 | $33,94444 claims |
| NovartisEntresto | $329 | $24,41148 claims |
| Johnson & JohnsonXarelto | $88 | $23,35925 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $17 | $19,71537 claims |
| AbbVieLinzess | $18 | $12,03630 claims |
| BayerKerendia | $272 | $10,28414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 40 geriatric medicine providers in Louisiana.
Other geriatric medicine in Haynesville
- Latrice RobertsRayville$6K
- Amy DevineMetairie$2K
- William LacorteMetairie$1K
- Charles HaddadSlidell$794
- Abir AbdoHammond$765
- Fadi Abu-FarsakhNew Orleans$534
- Mariam AhmedKenner$497
- Jay St JohnNew Orleans$350
- Kerry-Ann MillerCovington$347
- Mohammed SheikhIndependence$345
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.